» Articles » PMID: 16105887

Relation Between Viral Fitness and Immune Escape Within the Hepatitis C Virus Protease

Overview
Journal Gut
Specialty Gastroenterology
Date 2005 Aug 18
PMID 16105887
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The hepatitis C virus (HCV) mutates within human leucocyte antigen (HLA) class I restricted immunodominant epitopes of the non-structural (NS) 3/4A protease to escape cytotoxic T lymphocyte (CTL) recognition and promote viral persistence. However, variability is not unlimited, and sometimes almost absent, and factors that restrict viral variability have not been defined experimentally.

Aims: We wished to explore whether the variability of the immunodominant CTL epitope at residues 1073-1081 of the NS3 protease was limited by viral fitness.

Patients: Venous blood was obtained from six patients (four HLA-A2+) with chronic HCV infection and from one HLA-A2+ patient with acute HCV infection.

Methods: NS3/4A genes were amplified from serum, cloned in a eukaryotic expression plasmid, sequenced, and expressed. CTL recognition of naturally occurring and artificially introduced escape mutations in HLA-A2-restricted NS3 epitopes were determined using CTLs from human blood and genetically immunised HLA-A2-transgenic mice. HCV replicons were used to test the effect of escape mutations on HCV protease activity and RNA replication.

Results: Sequence analysis of NS3/4A confirmed low genetic variability. The major viral species had functional proteases with 1073-1081 epitopes that were generally recognised by cross reactive human and murine HLA-A2 restricted CTLs. Introduction of mutations at five positions of the 1073-1081 epitope prevented CTL recognition but three of these reduced protease activity and RNA replication.

Conclusions: Viral fitness can indeed limit the variability of HCV within immunological epitopes. This helps to explain why certain immunological escape variants never appear as a major viral species in infected humans.

Citing Articles

Frequency of the Main Human Leukocyte Antigen A, B, DR, and DQ Loci Known to Be Associated with the Clearance or Persistence of Hepatitis C Virus Infection in a Healthy Population from the Southern Region of Morocco: A Preliminary Study.

Machraoui S, Errafii K, Oujamaa I, Belghali M, Hakmaoui A, Lamjadli S Diseases. 2024; 12(5).

PMID: 38785761 PMC: 11120154. DOI: 10.3390/diseases12050106.


CD8 T-Cell Exhaustion Phenotype in Chronic Hepatitis C Virus Infection Is Associated With Epitope Sequence Variation.

Osuch S, Laskus T, Perlejewski K, Berak H, Bukowska-Osko I, Pollak A Front Immunol. 2022; 13:832206.

PMID: 35386708 PMC: 8977521. DOI: 10.3389/fimmu.2022.832206.


Adaptive Immune Responses, Immune Escape and Immune-Mediated Pathogenesis during HDV Infection.

Oberhardt V, Hofmann M, Thimme R, Neumann-Haefelin C Viruses. 2022; 14(2).

PMID: 35215790 PMC: 8880046. DOI: 10.3390/v14020198.


In the era of rapid mRNA-based vaccines: Why is there no effective hepatitis C virus vaccine yet?.

Echeverria N, Comas V, Aldunate F, Perbolianachis P, Moreno P, Cristina J World J Hepatol. 2021; 13(10):1234-1268.

PMID: 34786164 PMC: 8568586. DOI: 10.4254/wjh.v13.i10.1234.


Expansion of Unique Hepatitis C Virus-Specific Public CD8 T Cell Clonotypes during Acute Infection and Reinfection.

Mazouz S, Boisvert M, Abdel-Hakeem M, Khedr O, Bruneau J, Shoukry N J Immunol. 2021; 207(4):1180-1193.

PMID: 34341170 PMC: 8434894. DOI: 10.4049/jimmunol.2001386.


References
1.
Lauer G, Ouchi K, Chung R, Nguyen T, Day C, Purkis D . Comprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities. J Virol. 2002; 76(12):6104-13. PMC: 136241. DOI: 10.1128/jvi.76.12.6104-6113.2002. View

2.
Bartenschlager R, Lohmann V, Wilkinson T, Koch J . Complex formation between the NS3 serine-type proteinase of the hepatitis C virus and NS4A and its importance for polyprotein maturation. J Virol. 1995; 69(12):7519-28. PMC: 189690. DOI: 10.1128/JVI.69.12.7519-7528.1995. View

3.
Wentworth P, Sette A, Celis E, Sidney J, Southwood S, Crimi C . Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome. Int Immunol. 1996; 8(5):651-9. DOI: 10.1093/intimm/8.5.651. View

4.
Rehermann B, Chang K, McHutchison J, Kokka R, Houghton M, Chisari F . Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J Clin Invest. 1996; 98(6):1432-40. PMC: 507570. DOI: 10.1172/JCI118931. View

5.
Pascolo S, Bervas N, Ure J, Smith A, Lemonnier F, Perarnau B . HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice. J Exp Med. 1997; 185(12):2043-51. PMC: 2196346. DOI: 10.1084/jem.185.12.2043. View